Table 2.
The debut of cerebral vasospasm (CVS), the number of procedures per patient, the vasospastic territory and the distribution of intra-arterial nimodipine (IAN).
| Vasospasm debut days after SAH on TCD/radiology, median (range) | 5 (0–30) |
| IAN days after SAH, median (range) | 7 (3–30) |
| IAN days after vasospasm debut, median (range) | 2 (0–13) |
| IAN total number of procedures | 124 |
| Number of procedures/patients, median (range) | 2 (1–10) |
| 1 | 17 (35%) |
| 2 | 13 (27%) |
| 3 | 6 (13%) |
| 4 | 7 (15%) |
| 5 | 1 (2%) |
| 6 | 1 (2%) |
| 7 | 2 (4%) |
| 10 | 1 (2%) |
| Dose/procedure, median (range) | 4 mg (2–9) |
| Vasospastic territory, n (%) | |
| ACA | 116 (46%) |
| ICA | 16 (6%) |
| MCA | 98 (39%) |
| Posterior circulation | 24 (9%) |
| IAN distribution, n (%) | |
| ACA | 48 (24%) |
| ICA | 104 (53%) |
| MCA | 29 (15%) |
| Posterior circulation | 16 (8%) |
ICA: internal carotid artery; SAH: subarachnoid haemorrhage: TCD: Transcranial doppler, ACA: Anterior cerebral artery, MCA: Middle cerebral artery.